Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 https://t.co/2PQ7ZHc1yB $ONWD $ONWRY

🎧Vanguards of Health Care: Onward Medical Brings Hope Back for SCI

We recently announced that the US FDA has approved an investigational device exemption (IDE) for the ONWARD ARC-IM System. This approval allows the initiation of Empower BP, a global pivotal study to assess the safety and efficacy of the implantable neurostimulation technology in

We recently announced that the US FDA has approved an investigational device exemption (IDE) for the ONWARD ARC-IM System. This approval allows the initiation of Empower BP, a global pivotal study to assess the safety and efficacy of the implantable neurostimulation technology in

Don’t miss our upcoming webinar with @onwdempowered! 📌 Research update: The Empower BP study is launching 🗓️ Wednesday, September 25 ⏰ 12 PM ET ✅ Register: https://t.co/9VxbV2NljB

We are proud to announce the simultaneous publications of two articles in the highly respected academic journals @Nature and @NatureMedicine. They highlight advances in blood pressure regulation after spinal cord injury and add to the compelling body of scientific and clinical

We are pleased to announce that we have received CE Mark certification for the ARC-EX® System, enabling commercialization of our breakthrough spinal cord stimulation system in the European Union and certain other countries

We are heading to Philadelphia for the 2025 ASCIP Annual Meeting! Organized by the Academy of Spinal Cord Injury Professionals , this conference is an opportunity for SCI experts to connect, exchange ideas, and support new research. If you’re attending the conference, come

Today, we announced our 2025 half-year results and business highlights. In this impactful year for ONWARD, we are demonstrating our ability to successfully meet demand for the ARC-EX® System while continuing to advance our innovation pipeline – driving forward our work to help

We are delighted to return and actively contribute to LSI Europe Medtech Summit in London, where innovators, leaders, and investors will gather from September 7 to 11. ONWARD CEO @onwddave will moderate a panel on September 10, focusing on engaging and building lasting

We are proud to return to the Paralyzed Veterans of America Healthcare Summit + Expo 2025, supporting this important event for the SCI, MS and ALS communities as a Gold Sponsor. Held from August 24-27 in New Orleans, the summit offers a unique opportunity to learn, share, and

Yesterday, we announced that the US Food and Drug Administration has approved an investigational device exemption for the ARC-IM® System, our implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation. With this IDE approval, we can

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System

We are delighted to announce the appointment of Lucas Buchanan as a non-executive member of our Board of Directors https://t.co/CVuK3y7J9v $ONWD $ONWRY

We are pleased to share the story about Walk The Line Recovery Therapy, which is one of the first US clinics to use our ARC-EX® System to improve hand sensation and strength after a spinal cord injury https://t.co/5at37S8Hwf ARC-EX Indication for Use (US): The ARC-EX System is

We are delighted to announce the appointment of entrepreneur and neurotechnology thought leader Professor Tim Denison to our Board of Directors.

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application https://t.co/8PnyUYJyhZ